H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade ; volume:12 ; number:1 ; day:10 ; month:2 ; year:2020 ; pages:1-12 ; date:12.2020
Clinical epigenetics ; 12, Heft 1 (10.2.2020), 1-12, 12.2020
- Urheber
-
Hoffmann, Friederike
Niebel, Dennis
Aymans, Pia
Ferring-Schmitt, Sandra
Dietrich, Dimo
Landsberg, Jennifer
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-020-0818-7
- URN
-
urn:nbn:de:101:1-2020051015510837919734
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hoffmann, Friederike
- Niebel, Dennis
- Aymans, Pia
- Ferring-Schmitt, Sandra
- Dietrich, Dimo
- Landsberg, Jennifer
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma